SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-184864
Filing Date
2014-05-06
Accepted
2014-05-06 16:11:38
Documents
9
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d690283d10q.htm 10-Q 363746
2 EX-31.1 d690283dex311.htm EX-31.1 7070
3 EX-32.1 d690283dex321.htm EX-32.1 4561
  Complete submission text file 0001193125-14-184864.txt   2190024

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT acad-20140331.xml EX-101.INS 247184
5 XBRL TAXONOMY EXTENSION SCHEMA acad-20140331.xsd EX-101.SCH 24259
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acad-20140331_cal.xml EX-101.CAL 41137
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acad-20140331_def.xml EX-101.DEF 62993
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE acad-20140331_lab.xml EX-101.LAB 189518
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acad-20140331_pre.xml EX-101.PRE 127962
Mailing Address 11085 TORREYANA ROAD SUITE 100 SAN DIEGO CA 92121
Business Address 11085 TORREYANA ROAD SUITE 100 SAN DIEGO CA 92121 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

IRS No.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50768 | Film No.: 14817199
SIC: 2834 Pharmaceutical Preparations